The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era
Abstract
Purpose: To determine whether pretreatment risk groups shown to predict time to prostate cancer–specific mortality (PCSM) after treatment at a single institution retained that ability in a multi-institutional setting. Patients and Methods: From 1988 to 2002, 7,316 patients treated in the United States at 44 institutions with either surgery (n = 4,946) or radiation (n = 2,370) for clinical stage T1c-2, N0 or NX, M0 prostate cancer made up the study cohort. A Cox regression analysis was performed to determine the ability of pretreatment risk groups to predict time to PCSM after treatment. The relative risk (RR) of PCSM and 95% confidence intervals (CIs) were calculated for the intermediate- and high-risk groups relative to the low-risk group. Results: Estimates of non-PCSM 8 years after prostate-specific antigen (PSA) failure were 4% v 15% (surgery versus radiation; P log rank = .002) compared with 13% v 18% (surgery versus radiation; P log rank = .35) for patients whose age at the time of PSA failure was less than 70 as compared with ≥ 70 years, respectively. The RR of PCSM after treatment for surgery-managed patients with high- or intermediate-risk disease was 14.2 (95% CI, 5.0 to 23.4; P Cox < .0001) and 4.9 (95% CI, 1.7 to 8.1; P Cox = .0037), respectively. These values were 14.3 (95% CI, 5.2 to 24.0; P Cox < .0001) and 5.6 (95% CI, 2.0 to 9.3; P Cox = .0012) for radiation-managed patients. Conclusion: This study provided evidence to support the prediction of time to PCSM after surgery or radiation on the basis of pretreatment risk groups for patients with clinically localized prostate cancer managed during the PSA era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Eastham, J. A., Stapleton, A. M. F., Wheeler, T. M., & Scardino, P. T. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.10.766 · Cited by 1,242
Consensus statement: Guidelines for PSA following radiation therapy1
AMERICANSOCIETYFORTHERAPEUTICR (1997) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/s0360-3016(97)00002-3 · Cited by 1,151
Catalona, W. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080052031 · Cited by 998
Zelefsky, M. J., Fuks, Z., Hunt, M., Yamada, Y., Marion, C., Ling, C. C., Amols, H., Venkatraman, E. S., & Leibel, S. A. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02857-2 · Cited by 775
Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D., & Brennan, M. F. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10476289 · Cited by 483
SOLOWAY, M. S., PAREEK, K., SHARIFI, R., WAJSMAN, Z., McLEOD, D., WOOD, D. P., PURAS-BAEZ, A., & THE LUPRON DEPOT NEOADJUVANT PROSTATE CANCER STUDY GROUP† (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65393-1 · Cited by 341
The capsure database: a methodology for clinical practice and research in prostate cancer
Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R., Carroll, P. R., & panel, T. C. R. (1996) · Urology · doi:10.1016/s0090-4295(96)00226-9 · Cited by 268
Self-citationGraefen, M., Karakiewicz, P. I., Cagiannos, I., et al. (2002) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(02)00177-1 · Cited by 76
Combined-modality staging for localized adenocarcinoma of the prostate.
Av, D. (2001) · PubMed · Cited by 65
Cited by
Turkbey, B., Shah, V. P., Pang, Y., Bernardo, M., Xu, S., Kruecker, J., Locklin, J., Baccala, A. A., Rastinehad, A. R., Merino, M. J., et al. (2011) · Radiology · doi:10.1148/radiol.10100667 · Cited by 389
Lalonde, E., Ishkanian, A. S., Sykes, J., Fraser, M., Ross-Adams, H., Erho, N., Dunning, M. J., Halim, S., Lamb, A. D., Moon, N. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71021-6 · Cited by 342
Golfam, M., Samant, R., Eapen, L., & Malone, S. (2012) · Current Oncology · doi:10.3747/co.19.963 · Cited by 11
Metadata
- Authors
- D’Amico, A. V., Moul, J., Carroll, P. R., Sun, L., Lubeck, D., & Chen, M.-H.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-06-01
- Volume
- 21
- Issue
- 11
- Pages
- 2163-2172
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105386786
- Cited by
- 455
- References
- 10
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era. https://app.cochat.ai/papers/10.1200/jco.2003.01.075
- The paper
- D’Amico, A. V., Moul, J., Carroll, P. R., Sun, L., Lubeck, D., & Chen, M.-H. (2003). Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2003.01.075
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
